African journal of medicine and medical sciences 1994-03-01

Antimalarial activity of cyclosporins A, C and D.

P O Uadia, I C Ezeamuzie, M J Ladan, R Gerrets

Index: Afr. J. Med. Med. Sci. 23(1) , 47-51, (1994)

Full Text: HTML

Abstract

Cyclosporin A (CsA) is an immunosuppressive drug widely used in organ transplants. It is also accumulated by the erythrocyte, a site that accommodates one of the stages of malaria parasite. We observe that CsA and its less potent immunosuppressive analogues CsC and CsD were as effective as chloroquine in inhibiting P. berghei malaria parasite development in vivo (when administered orally) and P. falciparum parasite in vitro. They were, however, not inhibitory to the liver stages and the gametocytes. In vivo the minimum effective dose was 10 mg/Kg administered on two consecutive days whereas, in vitro CsA and its analogues inhibited parasite development at concentrations of 10 micrograms/ml and above.


Related Compounds

Related Articles:

Comparison of the properties of the CsA analogs monoacetyl CyC (o-acetyl-threonine2 cyclosporin) and methyl-alanyl CsA (N-methyl-L-alanyl6 cyclosporin); monoacetyl cyclosporin is immunosuppressive without binding to cyclophilin.

1992-07-01

[Clin. Exp. Immunol. 89(1) , 136-42, (1992)]

Tachykinin antagonists screening from microbial origin.

1996-01-01

[J. Antibiot. 49(1) , 110-2, (1996)]

Monitoring cyclosporine by HPLC with cyclosporin C as internal standard.

1993-01-01

[Clin. Chem. 39(1) , 168, (1993)]

Use of 125I-labeled-histamine-cyclosporin C for monitoring serum cyclosporine concentrations in transplantation patients.

1986-03-01

[Clin. Chem. 32(3) , 492-5, (1986)]

Cyclosporin C(2) and C(0) concentration monitoring in stable, long-term heart transplant recipients receiving metabolic inhibitors.

2003-07-01

[J. Heart Lung Transplant. 22(7) , 715-22, (2003)]

More Articles...